{
  "id": "mhgap#risk_safety_ea2a5097",
  "content": "y Access to psychotherapy, particularly CBT, in line\nyoung people with depression on a case-by-case\nwith other mhGAP recommendations, remains\nbasis.\nimportant for adolescents with moderate-to-severe\ny It is important to inform adolescents and carers, as\ndepression.\nappropriate, about treatment options and jointly\ny In case psychosocial interventions alone prove\nreassess treatment goals and management plans on\nineffective, the adolescent and the caregiver, as\na regular basis.\nappropriate, should be referred to a specialist for\nResearch gaps careful consideration of benefits and risks associated\ny The available evidence on the effects of with initiation of fluoxetine, possibly in combination\nantidepressants in adolescents is of very low with psychological treatment, in close consultation\ncertainty and almost entirely from HICs. Adolescents with the adolescent and family, as appropriate.\nconsidered at risk of suicide are frequently excluded y Fluoxetine treatment should be offered only in\nfrom trials, so one cannot be confident about the the context of a management plan that addresses\neffects of these medicines for these individuals. psychosocial risks and vulnerabilities and\nThere is no evidence on reduction in risky environmental factors that have an impact on\nbehaviours and user/family satisfaction. depression symptoms and functioning.",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "high",
    "topics": [
      "relationships",
      "risk_safety",
      "screening_cues",
      "referral",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Risk Safety y Access to psychotherapy, particularly CBT, in line\nyoung people with depression on a case-by-case\nwith other mhGAP recommendations, remains\nbasis.\nimportant for adolescents with moderate-to-severe\ny It is important to inform adolescents and carers, as\ndepression.\nappropriate, about treatment options and jointly\ny In case psychosocial interventions alone prove\nreassess treatment goals and management plans on\nineffective, the adolescent and the caregiver, as\na regular basis.\nappropriate, should be referred to a specialist for\nResearch gaps careful consideration of benefits and risks associated\ny The available evidence on the effects of with initiation of fluoxetine, possibly in combination\nantidepressants in adolescents is of very low with psychological treatment, in close consultation\ncertainty and almost entirely from HICs. Adolescents with the adolescent and family, as appropriate.\nconsidered at risk of suicide are frequently excluded y Fluoxetine treatment should be offered only in\nfrom trials, so one cannot be confident about the the context of a management plan that addresses\neffects of these medicines for these individuals. psychosocial risks and vulnerabilities and\nThere is no evidence on reduction in risky environmental factors that have an impact on\nbehaviours and user/family satisfaction. depression symptoms and functioning. Y access to psychotherapy, particularly cbt, in line\nyoung people with trầm cảm on a case-by-case\nwith other mhgap recommendations, remains\nbasis. important for adolescents with moderate-to-severe\ny it is important to in..."
}